• H.R.905 - To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare. S.733 - A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare. S.89 - Withholding Tax Relief Act of 2011 S.164 - Withholding Tax Relief Act of 2011 H.R.1483 - Drug Safety Enhancement Act of 2011 H.R.3026 - Safeguarding America's Pharmaceuticals Act of 2011 S.1584 - Drug Safety and Accountability Act of 2011 H.R.2245 - Preserving Access to Life-Saving Medications Act of 2011 S.296 - Preserving Access to Life-Saving Medications Act H.R. 5651 - Food and Drug Administration Reform Act of 2012 S. 3187 - Food and Drug Administration Safety and Innovation Act

Duration: July 1, 2011 to July 31, 2012

General Issues: Health Issues, Medicare/Medicaid

Spending: about $90,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2011: House of Representatives, U.S. Senate, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Agency for Health Care Policy & Research, Congressional Budget Office (CBO), Government Accountability Office (GAO), Medicare Payment Advisory Commission (MedPAC), Executive Office of the President (EOP), Office of Management & Budget (OMB)